CEOs of The LYCRA Company and Qore® Join Global Fashion Summit Lineup
Article content
Article content
WILMINGTON, Del. — The LYCRA Company, a global leader in developing sustainable fibers and solutions for the apparel industry, announced today that its CEO, Gary Smith, is a speaker at the Global Fashion Summit: Copenhagen Edition 2025. He will be joined on stage by Jon Veldhouse, CEO of Qore ®, the maker of QIRA ®, a next-generation BDO and a key ingredient in bio-derived LYCRA ® fiber, which is launching later this year.
The CEOs of The LYCRA Company and Qore® will discuss the development of bio-derived LYCRA® fiber made with QIRA®, made from annually renewable field corn, during their Fireside Chat at the Global Fashion Summit: From Farm to Fashion.
Smith and Veldhouse will discuss the development of this sustainable fiber made from annually renewable field corn during their Fireside Chat: From Farm to Fashion. Their session takes place on Wednesday, June 4, at 3:35 CEST in the DR Concert Hall. The discussion will be moderated by Amy Nguyen, a researcher, writer, and founder of Sustainable & Social.
Article content
This is the first time both companies are participating in the Global Fashion Summit, a premier platform focused on sustainability in the fashion industry. The companies have a prominent exhibit space for attendees to learn more about bio-derived LYCRA ® fiber made with QIRA ®. Here, visitors can be transported to the Qore ® site and cornfields in Iowa through a virtual reality experience.
Article content
Bio-derived LYCRA ® EcoMade fiber will be the world's first large-scale, commercially available renewable elastane. It delivers equivalent performance to the original LYCRA ® fiber and serves as a one-to-one replacement with no re-engineering of fabrics, processes, or garment patterns required. The product contains 70 percent renewable content and can potentially reduce the carbon footprint of LYCRA ® fiber by up to 44 percent*. The LYCRA Company holds patents related to this renewable fiber in several regions including Europe.
Article content
'We're proud to join the Global Fashion Summit for the first time and showcase how collaboration can accelerate a more sustainable future for fashion,' said Gary Smith, CEO of The LYCRA Company. 'Partnering with Qore ® has enabled us to scale innovation that is renewable and ready to meet the demands of global fashion brands striving to meet their sustainability goals.'
Article content
The newly constructed Qore ® site in Eddyville, Iowa, began operating last month and has started producing QIRA ®. The company will host a grand opening celebration in July.
Article content
'Starting production at our new state-of-the-art facility marks a major step forward—not just for Qore ®, but for the entire industry,' said Jon Veldhouse, CEO of Qore ®. 'With QIRA ® now being made in Iowa from annually renewable field corn, we're turning sustainable innovation into reality and helping our partners bring next-generation materials to market.'
Article content
About The LYCRA Company
Article content
The LYCRA Company is a leading global fiber and technology solutions provider to the apparel and personal care industries committed to offering sustainable products using renewable, pre-, and post-consumer recycled ingredients that reduce waste and help set the stage for circularity. Headquartered in Wilmington, Delaware, United States, it owns the LYCRA ®, LYCRA HyFit ®, LYCRA ® T400 ®, COOLMAX ®, THERMOLITE ®, ELASPAN ®, SUPPLEX ® and TACTEL ® brands. The LYCRA Company adds value to its customers' products by offering unique innovations that meet the consumer's need for comfort and lasting performance. Learn more at lycra.com.
Article content
About Qore ® LLC
Article content
Formed through a joint venture by Cargill and HELM AG, Qore ® helps leading brands replace fossil-based chemistries with bio-derived intermediates. At the heart of the joint venture is the production of QIRA ®, the next-generation bio-derived 1,4-butanediol (BDO). Made biologically through the fermentation of plant-based sugars, QIRA ® can save up to 86% of greenhouse gas emissions when replacing today's widely used chemical intermediates made from traditional fossil sources. Bio-derived QIRA ® can be used the same way as its fossil counterpart but with significantly better environmental performance. For more information and inquiries, visit https://www.myqira.com/.
Article content
Article content
Article content
Article content
Article content
Article content
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
an hour ago
- Globe and Mail
Who is Jonathan Anderson, the man behind Dior's historic shakeup?
On Monday, luxury conglomerate LVMH named Jonathan Anderson the new creative director of Dior, making him the first designer since Christian Dior himself to oversee women's, men's and haute couture collections. LVMH had already announced in April that Anderson, 40, would succeed Kim Jones as artistic director of men's wear. Just last week, Maria Grazia Chiuri confirmed she would step down as the women's creative director at Dior after her final show in her hometown of Rome. Anderson's first men's wear collection will premiere this June, with women's wear to follow in October. For the first time in its 78-year history, Dior will skip the haute couture shows in July. 'It is a great honour to join the House of Dior as creative director of both women's and men's collections,' Anderson said in a statement. 'I have always been inspired by the rich history of this House–its depth and empathy. I look forward to working alongside its legendary Ateliers to craft the next chapter of this incredible story.' Anderson was born in 1984 and raised in Magherafelt, a town of 9,000 in Northern Ireland. At 18, he moved to Washington to study acting, but quickly discovered a passion for costume design. He moved to London and studied men's wear at the London College of Fashion, graduating in 2005, before working as a visual merchandiser for Prada. He eventually founded his namesake label, JW Anderson, in 2008. His fluid, conceptual collections made him a critical darling on London's fashion scene. In 2013, LVMH acquired a minority stake in the label and tapped Anderson to lead Loewe, then a middling Spanish house known for leather goods. In his 11-year tenure, Anderson turned Loewe into one of fashion's most relevant and sought-after brands, with annual revenues reportedly hitting US$2-billion a year. Industry insiders often compare Anderson to Karl Lagerfeld, another prolific visionary who balanced runway spectacle with commercial success. Speaking to the online publication Business of Fashion, Delphine Arnault, the chair and chief executive of Christian Dior Couture, called Anderson 'the most talented designer of his generation.' At Loewe, Anderson mastered the formula Lagerfeld invented during his decades at Chanel. Anderson would wow with a surrealist leather dress moulded to appear in constant motion while producing commercial hits including the ubiquitous Puzzle Bag. He also made Loewe a force in pop culture. Rising actors such as Ayo Edebiri, Josh O'Connor and Greta Lee starred in brand campaigns and wore Loewe on the red carpet. Loewe also sponsored the 2024 Met Gala. Dior is the second largest house in LVMH's stable, after only Louis Vuitton. Until now, it was considered too big a ship for one captain. Consolidating creative leadership in the hands of a sole designer means that Anderson can establish a unified vision. But 'there are huge implications,' wrote Lauren Sherman – the fashion journalist who pens Puck's Line Sheet newsletter – in an e-mail to The Globe and Mail. 'Anderson is of a new generation of designers that are coming into power at the peak of the luxury industry's consolidation curve. He'll need to act as a disrupter at an enormous company that generates around $10-billion a year on its own.' His appointment is also part of industry-wide turbulence: As the luxury sector slows and brands race to stay relevant, leadership changes are mounting. In 2025 alone, 17 fashion brands, including four at LVMH, announced new creative directors.
Globe and Mail
2 hours ago
- Globe and Mail
Vybrational Kreators: Elevating Conscious Streetwear to Luxury Status
Vybrational Kreators: Elevating Conscious Streetwear to Luxury Status In the fast-paced world of fashion, where trends shift overnight and brands compete for cultural relevance, Vybrational Kreators stands apart—not just as a clothing line, but as a movement. Founded by visionary entrepreneur Elijah McNear, Vybrational Kreators is more than a fashion brand. It's a billion-dollar symbol of individuality, consciousness, and luxury that speaks to a new generation of bold, creative minds. Vybrational Kreators: Elevating Conscious Streetwear to Luxury Status In the fast-paced world of fashion, where trends shift overnight and brands compete for cultural relevance, Vybrational Kreators stands apart—not just as a clothing line, but as a movement. Founded by visionary entrepreneur Elijah McNear, Vybrational Kreators is more than a fashion brand. It's a billion-dollar symbol of individuality, consciousness, and luxury that speaks to a new generation of bold, creative minds. A New Wave of Luxury At its core, Vybrational Kreators is a fusion of luxury fashion and elevated streetwear. This isn't your average designer label. The brand pushes boundaries, blending opulent fabrics, futuristic silhouettes, and unapologetically expressive designs. Every piece is created with the intention to awaken a 'higher frequency' in the wearer—speaking to those who are spiritually in tune, artistically driven, and unafraid to make a statement. From embroidered hoodies and premium joggers to fashion-forward outerwear and accessories, each collection is carefully curated to merge high fashion quality with urban cultural energy. The result? A style that resonates both on the runway and in the streets of the world's fashion capitals. Conscious Design Meets Creative Expression What truly makes Vybrational Kreators stand out in the saturated luxury market is its commitment to conscious design. Sustainability isn't a trend here—it's a foundation. The brand uses eco-friendly materials, ethical production processes, and partners with suppliers who share a commitment to reducing environmental impact. This dedication makes Vybrational Kreators a favorite among socially aware consumers who care about both style and substance. The brand's aesthetic is equally purpose-driven. Collections are themed around vibrational energy, spiritual empowerment, and creative freedom, with designs that challenge conventional fashion narratives. It's clothing that makes you feel seen—both as an individual and as part of a bigger cultural shift. Billion-Dollar Impact What started as an independent fashion label has quickly evolved into a billion-dollar global enterprise, proving there's a massive audience for bold, luxury-forward streetwear that doesn't sacrifice ethics for style. Vybrational Kreators has built an impressive fanbase, from fashion influencers and celebrities to tastemakers across the entertainment and art worlds. The brand's rise speaks to a cultural hunger for authenticity, boldness, and alignment between personal values and personal style. A Brand Built on Community More than just a retailer, Vybrational Kreators is a lifestyle platform. The brand leverages social media not only to promote its products but to uplift its community. Campaigns regularly spotlight real customers, creators, and changemakers who embody the VK spirit. The brand also invests in mentorship programs and collaborative design opportunities for emerging designers, helping foster the next generation of creative talent. The Future of Fashion Looking ahead, Vybrational Kreators is expanding its footprint globally, with plans for international pop-ups, tech-integrated fashion pieces, and exclusive luxury drops. But even as it scales, the brand stays grounded in its original mission: to elevate consciousness through creativity. In a world where fashion often feels fleeting, Vybrational Kreators offers something timeless—a connection to self, to community, and to purpose. This is luxury fashion with a soul.
Globe and Mail
5 hours ago
- Globe and Mail
Bristol Myers Collaborates With BNTX for Oncology Candidate
BMY announced a strategic collaboration agreement with BioNTech BNTX. Both companies have entered into an agreement for the global co-development and co-commercialization of BioNTech's investigational bispecific antibody BNT327 across numerous solid tumor types. BNT327 is a novel investigational bispecific antibody combining two complementary, validated mechanisms in oncology into a single molecule. Shares of BNTX surged on the deal announcement. Shares of Bristol Myers lost 12.8% year to date compared with the industry 's decline of 2.2%. More on BMY & BNTX Agreement Per the terms, BMY and BNTX will jointly develop and commercialize BNT327, including the development of BNT327 as monotherapy and in combination with other products. Both BMY and BNTX own the right to develop BNT327 independently in further indications and combinations, including combinations of BNT327 with proprietary pipeline assets. Per the terms, BMY will make an upfront payment of $1.5 billion to BioNTech. In addition, BNTX will also receive $2 billion in non-contingent anniversary payments through 2028. BioNTech is also eligible to receive up to $7.6 billion in additional development, regulatory and commercial milestones. Both the companies will jointly share development and manufacturing costs along with profits on an equal basis. BNT327, a next-generation bispecific antibody candidate, targets PD-L1 and VEGF-A. It is currently being evaluated in multiple ongoing trials with more than 1,000 patients treated to date, including phase III studies with registrational potential evaluating BNT327 as first-line treatment in extensive stage small cell lung cancer (ES-SCLC) and non-small cell lung cancer (NSCLC). A phase III study evaluating the candidate in triple negative breast cancer (TNBC) is planned to start by the end of 2025. Data from ongoing trials (on a preliminary basis) underscore the potential for combining anti-PD-L1 and anti-VEGF-A – two well-established therapeutic targets – into a single molecule to deliver synergistic clinical benefits for patients across multiple tumor types. BMY Looks to Diversify Business BMY is depending on newer drugs like Opdualag, Reblozyl and Breyanzi to stabilize its revenue base as its legacy drugs face generic competition. BMY earlier won FDA approval for xanomeline and trospium chloride (formerly KarXT), an oral medication for the treatment of schizophrenia, in adults, under the brand name Cobenfy. The approval broadens BMY's portfolio. Cobenfy represents the first new pharmacological approach to treating schizophrenia in decades. This drug is expected to contribute meaningfully to BMY's top line in the coming years. BMY has experienced a few pipeline setbacks in recent months, which negatively impacted its share price. The late-stage ODYSSEY-HCM study evaluating cardiovascular drug Camzyos for the treatment of adult patients with symptomatic New York Heart Association (NYHA) class II-III non-obstructive hypertrophic cardiomyopathy did not meet its dual primary endpoints. The top-line results from the phase III ARISE study on schizophrenia drug Cobenfy were also disappointing. The study is evaluating the efficacy and safety of the drug as an adjunctive treatment to atypical antipsychotics in adults with inadequately controlled symptoms of schizophrenia. Developing bispecific antibodies that target two proteins, namely PD-1 and VEGF, has lately been one of the lucrative areas in cancer treatment. In November, Merck signed a deal with China-based LaNova Medicines for the latter's PD-1xVEGF targeting bispecific antibody candidate, LM-299. The latest entrant into this space is Pfizer PFE, which recently entered a multi-billion-dollar deal with Chinese biotech 3SBio for the latter's PD-1/VEGF bispecific antibody SSGJ-707. The deal is expected to be complete in third-quarter 2025. BMY's Zacks Rank & Stocks to Consider Bristol Myers currently carries a Zacks Rank #3 (Hold). A couple of better-ranked stocks in the pharma/biotech sector are Novartis NVS and Pfizer, both carrying a Zacks Rank #2 (Buy) at present. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. The Zacks Consensus Estimate for Novartis' 2025 earnings per share (EPS) has risen from $8.47 to $8.74 over the past 60 days. EPS estimates for 2026 have jumped 20 cents to $9.02 during this timeframe. The stock has risen 18.6% so far this year. Pfizer's 2025 EPS estimate has risen from $2.97 to $3.06 in the past 60 days, while that for 2026 has gone up from $2.99 to $3.09 over the same timeframe. Zacks' Research Chief Names "Stock Most Likely to Double" Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest. This top pick is among the most innovative financial firms. With a fast-growing customer base (already 50+ million) and a diverse set of cutting edge solutions, this stock is poised for big gains. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months. Free: See Our Top Stock And 4 Runners Up Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Novartis AG (NVS): Free Stock Analysis Report Bristol Myers Squibb Company (BMY): Free Stock Analysis Report Pfizer Inc. (PFE): Free Stock Analysis Report BioNTech SE Sponsored ADR (BNTX): Free Stock Analysis Report
